A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer. - Wikidata - wikimedia - TriplyDB

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.

http://www.wikidata.org/entity/Q35134354

about

Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy Oral vinorelbine in the treatment of non-small-cell lung cancer.Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC.

P2860

Q36005030-4A6CC749-F7DB-4A21-9DCB-522F241D87ED Q36131115-181D06DC-7D1E-4CDB-93FF-C6F82F3774D8 Q38223910-3CC84FF6-D53A-4B27-8C81-AAFFDE948F7B Q38638654-610C0DCE-B5E8-4413-B8D6-49F6261063A3 Q38957328-227C3E67-738B-486A-83E9-D8EA9C2721D9

P2860

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.

http://www.wikidata.org/entity/Q35134354

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@ast

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@en

type

label

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@ast

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@en

prefLabel

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@ast

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@en

P1433

Q35134354-8515D8A5-93F2-444A-80EE-D67D286EAB4F

P1476

Q35134354-D2BE1855-D335-4086-AB6D-C9D934987971

P2093

Q35134354-0646C061-A932-4E79-B41E-AE337C44264B

Q35134354-0DA0783D-545C-42D4-ACCB-2E7865996233

Q35134354-1611EFD5-1D62-4A26-9F5B-F31B84F61775

Q35134354-18F84290-1400-48BF-8836-3F968285AD95

Q35134354-26892831-BB80-47CE-8CF8-B91518594531

Q35134354-362673F7-EBF3-485C-B671-F961F063CDBD

Q35134354-42E48027-448D-4BBB-A7F4-DFCFB40644A5

Q35134354-66F9CDAC-1571-4648-9FDA-252B4800EA8C

Q35134354-A29576A3-44FD-41BB-BDCD-C82E2BD8ACB8

Q35134354-AD9DD4D4-C330-4256-9496-DF9F7B0A33E3

P2860

Q35134354-12B706C0-21FC-452D-8F32-8A02F296EB70

Q35134354-147129B9-E53D-4A4B-8FDD-45DD2E1B4848

Q35134354-17F896D8-035C-4BAB-A028-EDD52B79D905

Q35134354-1F648189-8669-41B1-9833-0BB78D4B338A

Q35134354-2AAF90DF-A4CC-44AC-806E-BA74DBDB66C2

Q35134354-2E99B99D-3878-4CD9-BA23-188322F5A36C

Q35134354-42E58839-5A61-4E35-A918-2B0E69882203

Q35134354-5A0DB4B5-2172-43F7-99DD-DE701C65EF89

Q35134354-6FE048AF-4513-4EC8-B694-A7E71D88B10F

Q35134354-8775A517-355B-4A7E-BCBF-64503778AD14

P2888

Q35134354-F3B3C013-B523-4584-BF1C-A0BFB972B3C3

P304

Q35134354-6E667983-0D9C-4139-87E7-AC150D5ABEDD

P31

Q35134354-23BA9CEF-A454-4D61-A34E-D13AD6CA5868

P356

Q35134354-BF813020-DE8D-4FA6-9E5D-00249C613B16

P407

Q35134354-3EEA264F-ED66-4030-A0C0-2D92F296F54D

P478

Q35134354-CA991356-EFEE-4FB1-BBC0-77D82913CD2A

P50

Q35134354-F9DE3472-785E-4059-AD08-22EFA7EE5118

P577

Q35134354-31F305AD-36EC-4862-90AD-E87592A4822F

P5875

Q35134354-FB3FB22F-6C02-4E76-B7E6-E4D7613572D3

P6179

Q35134354-FB952080-97C1-4FD6-8C46-145D709C22DE

P698

Q35134354-90720BF1-902A-4F85-A49D-5BF8A8A47674

P921

Q35134354-CCBC54F1-08B6-4AA0-867C-A8461906D0F2

P932

Q35134354-0608D451-6EC3-40CF-94F2-8D34ECAE2083

P356

1471-2407-14-231

P1433

P1476

A phase II study of cisplatin ...... ed non-small cell lung cancer.

@en

P2093

Alain Rivière

http://www.w3.org/2001/XMLSchema#string

Armelle Lavole

http://www.w3.org/2001/XMLSchema#string

Bénédicte Precheur-Agulhon

http://www.w3.org/2001/XMLSchema#string

Cécile Dujon

http://www.w3.org/2001/XMLSchema#string

Delphine Lerouge

http://www.w3.org/2001/XMLSchema#string

Elizabeth Fabre

http://www.w3.org/2001/XMLSchema#string

Eric Dansin

http://www.w3.org/2001/XMLSchema#string

Eric Lartigau

http://www.w3.org/2001/XMLSchema#string

Francis Martin

http://www.w3.org/2001/XMLSchema#string

Gérard Zalcman

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Epidemiology of lung cancer: looking to the future.

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (G

Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung can

P2888

1471-2407-14-231

P304

231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-231

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Christos Chouaid

P577

2014-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261217704

http://www.w3.org/2001/XMLSchema#string

P6179

1046730240

http://www.w3.org/2001/XMLSchema#string

P698

24678902

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3986598

http://www.w3.org/2001/XMLSchema#string